NCT00688766 2012-12-11Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and SunitinibInfinity Pharmaceuticals, Inc.Phase 3 Terminated47 enrolled